Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
Status: Terminated
Location: See all (35) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject is male or female ≥ 18 years of age.
• Subject has an untreated hematologic malignancy.
• Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator.
Locations
United States
Arkansas
Mercy Fort Smith
Fort Smith
CARTI Cancer Center
Little Rock
California
Marin Cancer Care
Greenbrae
Alliance Research Centers
Laguna Hills
North County Oncology
Oceanside
Connecticut
Middlesex Hospital
Middletown
The Stamford Hospital
Stamford
Florida
Mid-Florida Hematology and Oncology Center
Orange City
Illinois
PMG Research, INC
Downers Grove
Illinois CancerCare-Peoria
Peoria
Orchard Healthcare Research, Inc.
Skokie
Carle Cancer Center NCI
Urbana
Indiana
Indiana Blood and Marrow Transportation
Indianapolis
Kentucky
St. Elizabeth Medical Center
Edgewood
Baptist Health Lexington
Lexington
Baptist Health Louisville
Louisville
Baptist Health Paducah
Paducah
Maryland
RCCA MD Inc.
Bethesda
Michigan
Cancer Research Consortium of West Michigan
Grand Rapids
Minnesota
HealthPartner Institute
Bloomington
Missouri
Mercy Joplin
Joplin
Mercy St. Louis
Saint Louis
Mercy Springfield
Springfield
North Carolina
East Carolina University Brody School of Medicine
Greenville
FirstHealth Outpatient Cancer Center
Pinehurst
Oklahoma
Mercy Oklahoma City
Oklahoma City
South Carolina
Bon Secours St Francis Cancer Center
Greenville
Spartanburg Regional Healthcare District
Spartanburg
Lexington Medical Center
West Columbia
South Dakota
Rapid City Regional Hospital
Rapid City
Utah
Community Cancer Trials of Utah
Ogden
Washington
Wenatchee Valley Hospital
Wenatchee
Wisconsin
Dean Clinic - Fort Atkinson Specialty Services
Fort Atkinson
ProHealth Care
Oconomowoc
West Virginia
CAMC Clinical Trials Center
Charleston
Time Frame
Start Date: 2018-12-07
Completion Date: 2020-03-24
Participants
Target number of participants: 409
Treatments
Hematologic Malignancy
Subjects with clinically confirmed hematologic malignancy and who are treatment naive will provide a blood sample at the time of enrollment. No additional blood draws will occur.
Authors
Steven Jubelirer, Kathleen Yost, Charles Kuzma, Tony Flippin, Ira Oliff, Carl Gray, Abderrahim Khomani, Santosh Nair, Nicholas Lopez, Vamsi Vasireddy, Darla Liles, Peter Eisenberg, Steven Madden, Timothy Wassenaar, Kathryn Arrambide, Kamal Patel, Arvinda Padmanabhan, Amit Sanyal, Wangjian Zhong, Lindsay Overton, John Edwards, Ralph Boccia, Robert Siegel, Samir Dalia, Robert Levy, Kenneth Deck, Mohan Tummala, Nasir Shahab, Srinivas Jujjavarapu, Himani Singh, Bethany Sleckman
Sponsors
Leads: Exact Sciences Corporation